Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronic SQ BNP in Preclinical Systolic Dysfunction
NCT00405639Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 2006
- Primary completion
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in left ventricular systolic dysfunction (LVSD) comparing Nesiritide with Placebo (2 arms). Primary endpoint: Change in Urinary Sodium Excretion in Response to Saline Load at 12 weeks. Started Jun 2006; status: completed.
02
Drugs
nesiritide
03
Conditions
left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on NCT00405639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405639.